Topotecan and (22S)-Budesonide as potential Drug candidates against ORF3a in SARS-CoV-2 virus

Simple item page
dc.contributor.authorGanguly, Rik
dc.contributor.authorKumar Yadav, Shashi
dc.contributor.authorBhattacharjee, Atanu
dc.date.accessioned2022-05-18T09:49:09Z
dc.date.available2022-05-18T09:49:09Z
dc.date.issued2021
dc.identifier.issn0972 - 8406
dc.identifier.urihttps://dspace.nehu.ac.in/handle/1/16032
dc.language.isoenen_US
dc.publisherNEHU Publicationen_US
dc.subjectGlycoproteinen_US
dc.subjectReplicationen_US
dc.subjectInsilcoen_US
dc.subjectLipinskien_US
dc.subjectToxicityen_US
dc.subjectGriden_US
dc.titleTopotecan and (22S)-Budesonide as potential Drug candidates against ORF3a in SARS-CoV-2 virusen_US
dc.title.alternativeThe NEHU Journal Vol. XIX, No. 2 (July –December), 2021, pp 98-107en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
_The-NEHU-Journal-Vol-XIX-No-2-July-December-2021-107-117.pdf
Size:
486.58 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
NEHU Journal Vol 19, Issue No: 2, (July - December, 2021)